Introduction: Denosumab is a human monoclonal antibody that binds to the receptor activator of nuclear factor kB (RANKL), it is used in the treatment of Osteoporosis. The Giant Cell Tumor (GCT) and the Aneurysmal Bone Cyst (ABC) use the same RANKL, and for this reason this drug began to be used for its treatment. There is consensus on the use, dose-time and 12-month duration for Denosumab treatment of GCT. Not so for ABC. In unresectable, disabling or recurrent tumors, its use could be for life. The adverse events of the habitual use of the drug are known, but it is not known if these increase with time. The objective of the present work is to identify the possible adverse events of treatment with Denosumab for more than 12 months. Material and Method: Series of cases with a diagnosis of GCT or ABC in spine, treated with Denosumab for more than 12 months. Adverse events are: arthralgia, fatigue, spinal pain, pain in extremities, headache, hypokalaemia, hypocalcemia, osteonecrosis of the jaw, malignant transformation, pathological fractures. Results: Eight patients, 6 TCG and 2 ABC, with a mean age at diagnosis of 25,6 years; presenting a mean treatment of 4.18 years (range 1.7 - 8.7). Of 6 operated patients, 4 had recurrence (2 to 36 months after surgery). One patient had to suspend treatment due to necrosis of the jaw, another hypocalcemia, both returned to treatment when stabilized. Conclusions: A minor adverse event (hypocalcemia) and a major adverse event (jaw bone necrosis) were observed. Level of Evidence IV; Original.
Introduction: Arachnoiditis ossificans (AO) in the spine is a rare entity characterized by progressive calcification of the arachnoid and dural sac, with consequent neurological involvement. Objective: Review the causes, clinical manifestations, and complementary studies for their correct diagnosis. Method: Systematic review under PRISMA guidelines, with search in Pubmed, Lilacs, and Embase. Patient demographics (sex and age), history reported as a cause of AO and time elapsed between cause and diagnosis of AO, clinical manifestations, and complementary studies used for diagnosis were collected. Results: 38 articles, of which we collected 46 patients (25 women, 21 men), mean age of 52 years. The most frequent cause was previous spine surgery and myelography with fat-soluble contrast. The most frequent symptoms were insufficient muscle strength (74%) and pain (69%). CT was used in 76%. The most frequent location was thoracic (35%). Conclusion: Its pathogenesis is unclear; described as the final cause of a chronic inflammatory process in the arachnoid with the consequent bone metaplasia. Diagnosis usually precedes a long period of pain and progressive neurological symptoms. The most sensitive and specific complementary study for the diagnosis is the tomography without contrast, which should be requested in case of clinical suspicion. Level of Evidence II; Systematic Review.
Introducción: Los bloqueos facetarios intrarticulares y radiculares selectivos son útiles como método diagnóstico y terapéutico para el manejo del dolor lumbar crónico. El objetivo de este estudio fue describir y analizar los resultados de dichos bloqueos. Materiales y Métodos: Se realizó un estudio de cohorte retrospectivo con datos de pacientes sometidos a bloqueos facetarios intrarticulares y radiculares selectivos guiados por tomografía computarizada, entre enero de 2014 y febrero de 2015. Se analizaron los datos demográficos, el puntaje en la escala analógica visual antes del bloqueo y después, y se analizó la asociación de estos factores con los resultados. Resultados: El estudio incluyó a 68 pacientes con bloqueo facetario intrarticular y 89 con bloqueo radicular selectivo. En ambos grupos, el dolor mejoró significativamente (p <0,05). Hubo una asociación entre la mejoría del dolor con los bloqueos facetarios intrarticulares y el sexo y la edad, y entre la mejoría lograda por los bloqueos radiculares selectivos y el tipo de dolor inicial. Conclusiones: Los bloqueos facetarios intrarticulares y los bloqueos radiculares selectivos son un métododiagnóstico útil en el manejo del dolor lumbar crónico y su acción terapéutica es significativa, aunque hacen falta estudios para conocer su efecto analgésico a mediano y largo plazo, y así poder mejorar la calidad de vida de los pacientes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.